S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q2 2024

BVF Partners

Period: Q2 2024 Β· Filed: 2024-08-14
View on SEC EDGAR β†—
AUM
$3.57B
Total portfolio value
Positions
60
Reported securities
Top Holding
MLTX
26.8% $956.4M
QoQ Changes
+6 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MLTXMOONLAKE IMMUNOTHERAPEUTICS$956.4M26.81%$41.80$18.95-54.7%
26.8%
RVMDREVOLUTION MEDICINES INC$232.1M6.51%$38.81$189.24+387.6%
6.5%
KYMRKYMERA THERAPEUTICS INC$154.1M4.32%$30.95$113.51+266.8%
4.3%
IONSIONIS PHARMACEUTICALS INC$151.9M4.26%$47.11$81.80+73.6%
4.3%
MIRMMIRUM PHARMACEUTICALS INC$149.4M4.19%$34.16$125.59+267.6%
4.2%
GHRSGH RESEARCH PLC$121.3M3.40%$11.75$27.01+129.9%
3.4%
PTGXPROTAGONIST THERAPEUTICS INC$115.0M3.22%$35.20$131.62+273.9%
3.2%
CGEMCULLINAN THERAPEUTICS INC$100.3M2.81%$16.73$17.63+5.4%
2.8%
OLMAOLEMA PHARMACEUTICALS INC$98.8M2.77%$11.14$12.64+13.5%
2.8%
GPCRSTRUCTURE THERAPEUTICS INC$97.7M2.74%$40.00$53.45+33.6%
2.7%
XOMAXOMA CORP DEL$86.1M2.41%$24.90$43.00+72.7%
2.4%
KURAKURA ONCOLOGY INC$84.0M2.36%$21.20$11.10-47.6%
2.4%
FDMT4D MOLECULAR THERAPEUTICS IN$82.3M2.31%$21.34$13.00-39.1%
2.3%
AXSMAXSOME THERAPEUTICS INC$76.9M2.15%$81.03$244.31+201.5%
2.1%
CGONCG ONCOLOGY INC$76.3M2.14%$31.72$70.36+121.8%
2.1%
MRUSMERUS N V$75.7M2.12%β€”β€”
2.1%
ACIUAC IMMUNE SA$75.2M2.11%$3.98$2.51-36.9%
2.1%
TYRATYRA BIOSCIENCES INC$74.5M2.09%$17.28$30.62+77.2%
2.1%
ETNB89BIO INC$60.6M1.70%β€”β€”
1.7%
CELCCELCUITY INC$56.8M1.59%$16.64$107.95+548.7%
1.6%
THRDTHIRD HARMONIC BIO INC$56.8M1.59%β€”β€”
1.6%
AGIOAGIOS PHARMACEUTICALS INC$51.3M1.44%$43.38$37.58-13.4%
1.4%
ZYMEZYMEWORKS INC$50.0M1.40%$8.61$26.31+205.6%
1.4%
EPIXESSA PHARMA INC$46.0M1.29%β€”β€”
1.3%
IDYAIDEAYA BIOSCIENCES INC$40.8M1.14%$35.92$37.65+4.8%
1.1%
LKFTGALAPAGOS NV$38.9M1.09%$25.01$30.39+21.5%
1.1%
ANNXANNEXON INC$34.3M0.96%$5.05$5.46+8.1%
1.0%
RPTXREPARE THERAPEUTICS INC$34.1M0.96%β€”β€”
1.0%
FHTXFOGHORN THERAPEUTICS INC$30.5M0.85%$5.84$5.30-9.3%
0.8%
CALTCALLIDITAS THERAPEUTICS AB$29.2M0.82%β€”β€”
0.8%

Quarter-on-Quarter Activity

Q2 2024 vs. Q1 2024

New Positions (6)

TickerIssuerNotionalSince Filing
AXSMAXSOME THERAPEUTICS INC$76.9M+201.5%
CELCCELCUITY INC$56.8M+548.7%
AGIOAGIOS PHARMACEUTICALS INC$51.3M-13.4%
FHTXFOGHORN THERAPEUTICS INC$30.5M-9.3%
CDTXCIDARA THERAPEUTICS INC$4.1M
PIRSPIERIS PHARMACEUTICALS INC$2.5M

Exited Positions (8)

TickerIssuerNotional
SNDXSYNDAX PHARMACEUTICALS INC$44.6M
CDTXXXXXCIDARA THERAPEUTICS INC$6.3M
DCTHDELCATH SYS INC$5.7M
LXRXLEXICON PHARMACEUTICALS INC$4.0M
ANTXAN2 THERAPEUTICS INC$4.0M
KRONKRONOS BIO INC$3.8M
PIRSPIERIS PHARMACEUTICALS INC$3.8M
CRVSCORVUS PHARMACEUTICALS INC$0.6M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
GPCRSTRUCTURE THERAPEUTICS INC$62.9M+206.0%+33.6%
ETNB89BIO INC$13.5M+87.0%
CGEMCULLINAN THERAPEUTICS INC$45.8M+79.9%+5.4%
ELDNELEDON PHARMACEUTICALS INC$7.7M+45.5%
IONSIONIS PHARMACEUTICALS INC$46.6M+31.2%+73.6%
ACIUAC IMMUNE SA$32.0M+29.3%-36.9%
CGONCG ONCOLOGY INC$-6.4M+28.3%+121.8%
MRUSMERUS N V$22.9M+9.1%

Trimmed (6)

TickerIssuerNotionalShares Ξ”Since Filing
JANXJANUX THERAPEUTICS INC$-91.4M-84.9%
UNCYUNICYCIVE THERAPEUTICS INC$-3.9M-39.1%
CTMXCYTOMX THERAPEUTICS INC$-8.0M-20.7%
LKFTGALAPAGOS NV$-21.1M-15.8%+21.5%
KURAKURA ONCOLOGY INC$-18.0M-14.7%-47.6%
PTGXPROTAGONIST THERAPEUTICS INC$6.3M-11.6%+273.9%
← Back to Hedge Funds